Aptevo Therapeutics (NASDAQ:APVO) Now Covered by StockNews.com
Analysts at StockNews.com assumed coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Get Free Report) in a research report issued on Saturday. The firm set a “sell” rating on the biotechnology company’s stock. Aptevo Therapeutics Price Performance Shares of Aptevo Therapeutics stock opened at $0.34 on Friday. Aptevo Therapeutics has a 52 week low of […]
